---
title: "SFSEP — App Overview"
url: https://marlvel.ai/apps/sfsep
category: Medical
developer: Mikael Cohen
platforms: ios
rating: N/A (0 ratings)
pricing: free
report_level: overview
generated: 2026-04-30
last_verified: "2026-04-30T09:49:46.401Z"
---

<!-- SECTION: Key Insight -->
> **Key Insight:** SFSEP functions as a specialized clinical decision-support app providing standardized protocols and calculators for MS patient management.

<!-- SECTION: Quick Facts -->
| Metric | Value |
|--------|-------|
| Category | Medical |
| Rating | N/A ★ (0) |
| Pricing | free |
| Platforms | iOS |
| Latest Version (iOS) | 4.0 |
| Developer | Mikael Cohen |

<!-- SECTION: Summary -->
## What is SFSEP?

SFSEP is a medical reference tool developed by the French Multiple Sclerosis Society to provide clinicians with standardized clinical recommendations. The app serves as a digital resource for managing patient care through integrated calculators and decision-support tools.

<!-- SECTION: Key Features -->
## Key Features

- **Vaccination Assistant**: A tool designed to help clinicians determine required vaccinations for their patients.
- **UTI Risk Estimator**: A feature that estimates the risk of urinary tract infections and provides treatment guidance.
- **EDSS Calculator**: An integrated tool for calculating the Expanded Disability Status Scale score.
- **Society Updates**: A communication channel for users to stay informed about the latest recommendations published by the SFSEP.

<!-- SECTION: Target Audience -->
## Who is it for?

Healthcare professionals and clinicians managing patients with multiple sclerosis.

<!-- SECTION: Links -->
## Links

- [App Store](https://apps.apple.com/us/app/sfsep/id1450782564?uo=4)
- [Full Intelligence Report](https://marlvel.ai/apps/sfsep)

---
*This is an overview report. Sentiment analysis, competitive landscape, and SWOT analysis are available in the [full intelligence report](https://marlvel.ai/apps/sfsep).*
*Generated by [Marlvel.ai](https://marlvel.ai) — Independent app intelligence.*